Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C14H17FN2O3 |
Molecular Weight | 280.2948 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@H]1N(C(=O)OC(C)C)C2=C(NC1=O)C=CC(F)=C2
InChI
InChIKey=KELNNWMENBUHNS-NSHDSACASA-N
InChI=1S/C14H17FN2O3/c1-4-11-13(18)16-10-6-5-9(15)7-12(10)17(11)14(19)20-8(2)3/h5-8,11H,4H2,1-3H3,(H,16,18)/t11-/m0/s1
Molecular Formula | C14H17FN2O3 |
Molecular Weight | 280.2948 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Opaviraline (also known as GW 420867), a nonnucleoside reverse transcriptase inhibitor that was studied for the treatment of HIV infections. The drug participated in clinical trials phase II in Germany, in South Africa, and in the United Kingdom, however, these studies were discontinued.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:30:38 GMT 2023
by
admin
on
Fri Dec 15 16:30:38 GMT 2023
|
Record UNII |
Q3A8EU2NMU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C97453
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB07884
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
Q3A8EU2NMU
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
C90786
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
154048
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
300000034254
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
CHEMBL301370
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
178040-94-3
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
DTXSID60170415
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY | |||
|
8020
Created by
admin on Fri Dec 15 16:30:38 GMT 2023 , Edited by admin on Fri Dec 15 16:30:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|